Bay Shore Trust
CIK: 0001986593
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TELO
Telomir Pharmaceuticals, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About Bay Shore Trust
Bay Shore Trust (SEC CIK 0001986593) files insider reports with the SEC as 10% Owner of Telomir Pharmaceuticals, Inc. (TELO).
Signal8 holds 1 ownership filing by Bay Shore Trust, a Form 4, filed on Nov 25, 2024. Those filings report 1 transaction, the latest on Nov 21, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Bay Shore Trust's filings is in MIAMI, FL.
Recent filings by Bay Shore Trust
- Nov 21, 2024: Gift of TELO derivative securities (Form 4, code G).
Other insiders filing for Telomir Pharmaceuticals, Inc. (TELO)
- Whalen Matthew Pratt, Director
- MacPherson Edward Clouston, Director
- Del Giudice Matthew Paul, Director
- Mushak Andriy, Chief Financial Officer
- Aminov Erez, CEO and Chairman
- MIRA PHARMACEUTICALS, INC., 10% Owner